Japanese firms form monoclonal antibody manufacturing JV with an eye on biosims
Mitsubishi Gas Chemical and Nippon Kayaku have said they will start making monoclonal antibody drugs at a site in Niigata, Japan within two years.
Mitsubishi Gas Chemical and Nippon Kayaku have said they will start making monoclonal antibody drugs at a site in Niigata, Japan within two years.
Novacap has started building a sodium bicarbonate production facility in Singapore, citing Asian drug and food manufacturers as target customers.
Collegium Pharmaceutical has launched the first product formulated using its Deterx anti-abuse technology in the US.
Alcami has announced an upgrade to its laboratory service capabilities at the company’s Wilmington, NC-based headquarters.
The National Institutes of Health (NIH) has issued a policy on the use of a single Institutional Review Board (IRB) for multi-site research with the goal of streamlining the IRB review processes.
Scancell Holdings has stopped dosing in a long-term extension arm of a trial of its cancer vaccine SCIB1 after discovering the product is no longer within original specification.